×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Featured
Want to learn more about Pharmacovigilance and Risk Management Strategies Conference? You've come to the right site!
Program Committee
-
Stephen Knowles, MD, MRCP Chief Medical Officer
Halozyme Therapeutics, United States -
Lesley Wise, PhD, MSc Managing Director
Wise Pharmacovigilance and Risk Management, Ltd, United Kingdom -
Mariette Boerstoel-Streefland, MD, MBA, MS Senior Vice President, Worldwide Safety Officer
Bristol-Myers Squibb Company, United States -
Cheryl Campbell, MS Associate Director of Executive Operations/Outreach and Communications, OSE,CDER
FDA, United States -
E. Stewart Geary, MD Senior Vice President
Eisai Co., Ltd., Japan -
Lisa Melanie Harinstein, PharmD Team Leader, Division of Pharmacovigilance, FDA
FDA, United States -
Jeremy Jokinen, PhD, MS Vice President and Head, Safety Evidence and Sciences
Bristol-Myers Squibb Company, United States -
Annette Stemhagen, DrPH, PhD, FISPE Chief Science Officer
UBC, United States -
Sarah Vaughan Head of Vigilance Operations
Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom -
Annette S. Williams, MBA, RPh Vice President, Pharmacovigilance
IQVIA, United States -
Jo Wyeth, PharmD Associate Director for Postmarket Assessments, OMEPRM, OSE, CDER
FDA, United States -
Stella Blackburn, MD, MA, MSc, FFPM, FISPE, FRCP Strategy
Consultant, United Kingdom -
William Gregory, PhD Senior Director, Safety and Risk Management
Pfizer Inc, United States -
Valerie E. Simmons, MD, FFPM Senior Medical Fellow, Global Patient Safety
Eli Lilly and Company Ltd, United Kingdom
Have an account?